Argan Climbs as Investors Revisit Strong Earnings and Higher Dividend
Investivoq PriceTracker
Argan, Inc. (AGX) is up 8.2% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be continued buying tied to Argan’s strong fiscal second-quarter results and its recent dividend increase, rather than a brand-new company announcement today. No fresh October 6 filing or press release was easy to confirm, so part of the move could also be momentum as investors refocus on the company’s power-generation construction exposure and data-center-related electricity demand.
Details:
Sources:
SEC, SEC, Stock Analysis
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$AGX Insider Trading Activity
$AGX insiders have traded $AGX stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $AGX stock by insiders over the last 6 months:
- WILLIAM F JR GRIFFIN has made 0 purchases and 2 sales selling 50,000 shares for an estimated $36,984,100.
- DAVID HIBBERT WATSON (PRESIDENT AND CEO) has made 0 purchases and 3 sales selling 31,183 shares for an estimated $19,464,203.
- WILLIAM F. LEIMKUHLER has made 0 purchases and 4 sales selling 14,244 shares for an estimated $8,636,599.
- CHARLES EDWIN IV COLLINS (CHIEF EXECUTIVE OFFICER, GEMMA) has made 0 purchases and 2 sales selling 13,568 shares for an estimated $8,404,979.
- PETER W GETSINGER has made 0 purchases and 3 sales selling 9,728 shares for an estimated $6,633,577.
- JOHN RONALD JR. JEFFREY has made 0 purchases and 2 sales selling 6,334 shares for an estimated $4,031,332.
- CYNTHIA FLANDERS sold 2,596 shares for an estimated $1,729,740
- JOSHUA SCOTT BAUGHER (Chief Financial Officer) has made 0 purchases and 3 sales selling 1,360 shares for an estimated $920,667.
- ALEXANDER LISA LARROQUE sold 350 shares for an estimated $220,703
- KAREN SWEENEY sold 300 shares for an estimated $211,500
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$AGX Hedge Fund Activity
We have seen 298 institutional investors add shares of $AGX stock to their portfolio, and 242 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAVERICK CAPITAL LTD removed 464,759 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $371,133,299
- PRICE T ROWE ASSOCIATES INC /MD/ added 328,238 shares (+357.3%) to their portfolio in Q2 2026, for an estimated $262,114,454
- UBS GROUP AG removed 167,175 shares (-51.6%) from their portfolio in Q2 2026, for an estimated $133,497,596
- SURGOCAP PARTNERS LP added 149,983 shares (+inf%) to their portfolio in Q2 2026, for an estimated $119,768,924
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 144,771 shares (+inf%) to their portfolio in Q2 2026, for an estimated $115,606,882
- BANK OF NEW YORK MELLON CORP removed 135,232 shares (-45.0%) from their portfolio in Q2 2026, for an estimated $107,989,513
- FMR LLC added 101,730 shares (+999.7%) to their portfolio in Q2 2026, for an estimated $81,236,491
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$AGX Congressional Stock Trading
Members of Congress have traded $AGX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AGX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $50,000 on 06/30.
To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.